B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Myleran

276 PubMed studies analyzed ยท Evidence Score: 40

Research Domains

Myleran has been studied across 11 research domains including ๐Ÿ”ฌ Oncology, โœจ Skin & Hair, ๐Ÿซ Respiratory, ๐Ÿ›ก๏ธ Immunity, ๐Ÿ˜ด Sleep. The primary research focus is ๐Ÿ”ฌ Oncology with 9% of studies addressing this area.

Loading evidence profile...

This evidence profile for Myleran is generated deterministically from 276 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.